- You are here: Home
- Disease Models
- Respiratory Disease Models
Disease Models
- Oncology Models
-
Inflammation & Autoimmune Disease Models
- Rheumatoid Arthritis Models
- Glomerulonephritis Models
- Multiple Sclerosis (MS) Models
- Ocular Inflammation Models
- Sjögren's Syndrome Model
- LPS-induced Acute Lung Injury Model
- Peritonitis Models
- Passive Cutaneous Anaphylaxis Model
- Delayed-Type Hypersensitivity (DTH) Models
- Inflammatory Bowel Disease Models
- Systemic Lupus Erythematosus Animal Models
- Asthma Model
- Sepsis Model
- Psoriasis Model
- Atopic Dermatitis (AD) Model
- Scleroderma Model
- Gouty Arthritis Model
- Carrageenan-Induced Air Pouch Synovitis Model
- Carrageenan-Induced Paw Edema Model
- Experimental Autoimmune Myasthenia Gravis (EAMG) Model
- Cardiovascular Disease Models
-
Neurological Disease Models
- Alzheimer's Disease Modeling and Assays
- Seizure Models
- Parkinson's Disease Models
- Ischemic Stroke Models
- Acute Spinal Cord Injury (ASCI) Model
- Traumatic Brain Injury (TBI) Model
- Hypoxic-Ischemic Encephalopathy (HIE) Model
- Tourette Syndrome (TS) Model
- Amyotrophic Lateral Sclerosis (ALS) Model
- Huntington's Disease (HD) Model
- Intracerebral hemorrhage (ICH) Models
- Pain Models
- Metabolic Disease Models
- Liver Disease Models
- Rare Disease Models
- Respiratory Disease Models
- Digestive Disease Models
-
Urology Disease Models
- Cisplatin-induced Nephrotoxicity Model
- Unilateral Ureteral Obstruction Model
- 5/6 Nephrectomy Model
- Renal Ischemia-Reperfusion Injury (RIRI) Model
- Diabetic Nephropathy (DN) Models
- Passive Heymann Nephritis (PHN) Model
- Adenine-Induced Chronic Kidney Disease (CKD) Model
- Kidney Stone Model
- Doxorubicin-Induced Nephropathy Model
- Orthopedic Disease Models
- Ocular Disease Models
Respiratory Disease Models
Respiratory disease affects 1 in 5 people and is the third biggest cause of death in the world. Respiratory disease may affect any of the structures and organs that have to do with breathing, including the nasal cavities, the pharynx (or throat), the larynx, the trachea (or windpipe), the bronchi and bronchioles, the tissues of the lungs, and the respiratory muscles of the chest cage.
Animal models of respiratory disease serve a vital function in the development for novel therapeutic approaches. Respiratory system models are experimental systems that recreate aspects of human respiratory system development, function or disease. Animal models such as dog, rodent and pig can be used to study infectious and genetic respiratory illnesses.
Creative Bioarray provides a wide range of models in preclinical respiratory disease. Our disease models are suitable for testing new drugs or compounds that act on disease targets.
Our portfolio of respiratory disease models includes:
- Animal models for research in COVID-19
- Chronic obstructive pulmonary disease (COPD) model
- Pulmonary fibrosis model
- LPS-induced acute lung injury model
- Cough model
- Allergic rhinitis model
- Radiation-induced lung injury (RILI) model
- Asthma model
Our capabilities for analyses include but not limited to:
- Respiratory parameters (Whole Body Plethysmography)
- Cytokine level assessment
- Chemical induction
We typically combine these parameters with studies of specific biomarkers through histological assays and ELISA assays (cell biomarkers, cytokines). This combination of different technologies makes us an ideal and reliable supplier, enabling us to quickly answer the potential effects of your compounds on respiratory diseases and perform high-level studies. We also offer you the option to screen compounds with a simplified solution, so you can save time researching potential new drugs.
We have extensive experience and numerous scientific publications, while having a proven track record with compounds reaching clinical evaluation in this therapeutic area. To discuss any of these models further or to discuss the possibility of developing alternative models, please do not hesitate to contact us.
For research use only. Not for any other purpose.
